CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03236909
NCT03236909N/ACompleted
CompareCT.gov

Expanded Indications in the Adult Cochlear Implant Population

Med-El Corporation·interventional·Posted Aug 2, 2017·Updated Jun 24, 2025

In Brief

A clinical study evaluating MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System for Hearing Loss, Sensorineural. Completed, enrolled 44 participants across 5 sites in 2 countries.

Detailed Summary

The purpose of this investigation is to expand FDA-approved labeling for MED-EL cochlear implants to include adults who have moderate to profound sensorineural hearing loss and obtain limited benefit from appropriately fit hearing aids.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2, 2017
Enrollment StartApr 16, 2018
Primary CompletionMar 27, 2023
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 8.9 years ago

Interventions

MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant Systemdevice

Subjects will be implanted with the MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System with +FLEX28 or +FLEXSOFT electrode arrays. Subjects will be fit with the SONNETEAS (ear-level) and/or RONDO (single-unit) external audio processors.